Post by
canadafan on May 25, 2023 5:31pm
Results clear on some things, not on others..I’m not a Dr.
The results do show a clear improvement Pala + pactataxil alone.
cohort 2 vs #1.
beyond that. I'm not qualified to determine if this is over the top good or not.
No N.R., puzzles me.
Well tomorrow is yet another day....
The ambiguity does explain why a verbal communication & KOL followup is required.
Certainly not bad news.
The triplet combo, did not improve at all.
Comment by
Quentin30 on May 25, 2023 5:41pm
You said it Canada... more ambiguity... Have ONCY ever run a trial that proves beyond a shadow of a doubt that Pela works..?? The IND was only powered to 90%, meaning there was a 10% chance the data were a fluke... oh well, nothing to see until Q1 24 when the OS data is out.. GLTA
Comment by
Azzak34 on May 25, 2023 5:49pm
Hahaha what a tool! The numbers aren't even up to date and rheyre great. That's human beings still alive you parasite.
Comment by
fox7mf on May 25, 2023 5:44pm
+50% improvement in ORR & PFS...very very good.
Comment by
Noteable on May 25, 2023 5:51pm
The "triplet therapy" (Cohort 3) involving the addition of an immune checkpoint inhibitor resulted in a 70.6% disease control rate at 16 weeks versus a 46.7% control rate for the placebo of paclitaxel alone (Cohort 1). And this result occured in a heavily pre-treated group of metastatic breast cancer patients.